Starz (STRZ) Amends Form 4: RSU Grant and Ownership Updated
Rhea-AI Filing Summary
Amendment to Form 4 reporting RSU grant and corrected share calculation for an officer of Starz Entertainment Corp (STRZ). The filing reports that Jason Wyrick, an officer, was granted restricted stock units (RSUs) with an effective transaction date of 08/04/2025. The amendment corrects the previously reported share amount, noting the original calculation used the July 31, 2025 closing price in error; the corrected grant reflects the August 4, 2025 closing price and shows 4,647 RSUs granted on that date. Following the transaction, Mr. Wyrick beneficially owns 20,928 common shares including unvested RSUs. The RSUs vest on scheduled dates: 4,010 RSUs on 07/03/2026; 9,086 RSUs in two equal installments on 07/01/2026 and 07/01/2027; and 4,647 RSUs in three equal installments on 08/04/2026, 08/04/2027 and 08/04/2028.
Positive
- Amendment filed to correct grant calculation, improving disclosure accuracy
- Detailed vesting schedule provided for all RSU tranches (2026–2028), clarifying future dilution timing
- Post‑transaction beneficial ownership disclosed: 20,928 common shares
Negative
- Original filing used incorrect closing price (July 31, 2025) requiring an amendment
- Grant increases potential future dilution as RSUs vest over multiple years
Insights
TL;DR: Officer received time‑based RSUs and the company corrected the grant calculation; routine disclosure with limited immediate impact.
The amended Form 4 clarifies the number of RSUs granted to an officer by using the correct grant‑date closing price. Time‑based RSUs with multi‑year vesting align executive compensation with retention goals rather than immediate liquidity events. The correction improves disclosure accuracy but does not change the compensation structure or vesting schedule. For shareholders, the primary consideration is dilution over the vesting period and alignment of incentives; the filing provides the vesting timetable and post‑grant beneficial ownership figure of 20,928 shares.
TL;DR: Amendment addresses a technical calculation error; filing fulfills Section 16 reporting obligations.
The report rectifies an inadvertent use of an earlier closing price and restates the grant amount tied to the August 4, 2025 closing price. The signature by power of attorney indicates procedural completion. No derivative transactions or dispositions are reported. From a compliance perspective, timely amendment and clear explanation reduce regulatory risk; no evidence in the filing of insider sales or other reportable transactions beyond the grant.